Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Military Medicine
|
January 9, 2026
In Vitro Analysis of Flow Rates in Peripheral Catheter Devices: Implications for Emergency Fluid Resuscitation
Dominique M Ferguson, Matthew A Tovar, Mariah A Jensen-Wachspress, et al.
Frontiers in Immunology
|
October 30, 2020
T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1
Katherine M Harris, Sarah E Horn, Melanie L Grant, et al.
Molecular Therapy. Methods & Clinical Development
|
May 4, 2022
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products
Jessica Durkee-Shock, Christopher A Lazarski, Mariah A Jensen-Wachspress, et al.
Nature Communications
|
March 30, 2024
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication
Michael D Keller, Stefan A Schattgen, Shanmuganathan Chandrakasan, et al.
Blood
|
December 17, 2020
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
Michael D Keller, Katherine M Harris, Mariah A Jensen-Wachspress, et al.
Nature Communications
|
April 18, 2024
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Military Medicine
|
January 9, 2026
In Vitro Analysis of Flow Rates in Peripheral Catheter Devices: Implications for Emergency Fluid Resuscitation
Dominique M Ferguson, Matthew A Tovar, Mariah A Jensen-Wachspress, et al.
Frontiers in Immunology
|
October 30, 2020
T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1
Katherine M Harris, Sarah E Horn, Melanie L Grant, et al.
Molecular Therapy. Methods & Clinical Development
|
May 4, 2022
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products
Jessica Durkee-Shock, Christopher A Lazarski, Mariah A Jensen-Wachspress, et al.
Nature Communications
|
March 30, 2024
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication
Michael D Keller, Stefan A Schattgen, Shanmuganathan Chandrakasan, et al.
Blood
|
December 17, 2020
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
Michael D Keller, Katherine M Harris, Mariah A Jensen-Wachspress, et al.
Nature Communications
|
April 18, 2024
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment
Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, et al.
Page
of 1